oral semaglutide weight loss studies 50 mg of #semaglutide daily was associated with body reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj Now that oral semaglutide (#wegovy)
Description
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common disease that happens when fat builds up in your liver
Mechanistically, these effects are linked to GLP-1 RA-mediated suppression of inflammatory pathways, modulation of skeletal muscle metabolism, and preservation of mitochondrial function, thereby influencing insulin resistance
"Ozempic face" is a colloquial term describing the gaunt or hollowed appearance after significant weight loss when using GLP-1 medications.
Bile acids modulate gastric emptying as well as small and intestinal colonic motility
